MRE Biomarker Ctte: Difference between revisions

From QIBA Wiki
Jump to navigation Jump to search
No edit summary
Line 1: Line 1:
:Co-chairs: Richard L. Ehman, MD; Patricia Cole, PhD, MD
:Co-chairs: Richard L. Ehman, MD; Patricia Cole, PhD, MD
:RSNA Staff Support: Susan Stanfa
* [https://docs.google.com/spreadsheets/d/e/2PACX-1vRXlDgOiADuCP3e9iHApSt4Z3zpel94OJN12IEQY8C4OT4u4LiiNnp9EWBP5FnCAgDL-YMe-m1NjasH/pubhtml?gid=1930876020&single=true Roster]
* [https://docs.google.com/spreadsheets/d/e/2PACX-1vRXlDgOiADuCP3e9iHApSt4Z3zpel94OJN12IEQY8C4OT4u4LiiNnp9EWBP5FnCAgDL-YMe-m1NjasH/pubhtml?gid=1930876020&single=true Roster]



Revision as of 16:43, 21 December 2023

Co-chairs: Richard L. Ehman, MD; Patricia Cole, PhD, MD


Project Snapshot

The MRE Biomarker Committee seeks to develop a quantitative Profile for MRE.

MRE Profile to be data-driven:

  • focusing on the characterization of bias and precision in MRE measurement targets for achieving these measurements
  • focusing on issues important to specific reproducibility


Meetings

Approved call summaries:
Note: The last meeting of this group was held on December 20, 2021; notes are posted after they are approved by the MRE BC during the following t-con

MRE BC Call Summaries Archive

MRE Profile Development

Working Documents

Statistical Reference Documents

Workflow Documents

Reference Materials